A Commentary on Realities of Developing COVID-19 Vaccines Discussed through the Global Health Safety Perspective

被引:6
作者
Al-Qahtani, Wedad Saeed [1 ]
Safhi, Fatmah Ahmed [2 ]
机构
[1] Naif Arab Univ Secur Sci, Dept Forens Sci, Coll Criminal Justice, Riyadh 11452, Saudi Arabia
[2] Princess Nourah Bint Abdulrahman Univ, Dept Biol, Coll Sci, Riyadh 11452, Saudi Arabia
关键词
COVID-19; SARS-CoV-2; vaccine; realities; possible concerns; health safety perspective; SARS-COV;
D O I
10.3390/vaccines9030274
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
SARS-CoV-2 (or simply COVID-19) remains to be a global pandemic issue affecting millions, thus urging the world's scientific community to develop efficient vaccine and design adequate measures of disease control. Currently, the most economically viable solution to infections and viruses is vaccination, despite the possible concerns about side effects from implementing quickly developed vaccine. The current commentary intends to explain the health and safety related to COVID-19 vaccines via a prism of global health safety. Scientists across the globe, along with companies from both public and private sectors, have predictably arranged cooperative programs to learn about COVID-19, along with taking simultaneous steps on devising vaccine and preparing effective treatments plans. Presently, several clinical trials to approve the efficiency of proposed vaccine solutions have been made successfully. Global health safety concerns on vaccine's efficiency such as high costs of production, provision of vaccine to developing countries, and its influence on the global economy are addressed. This commentary reflects on current efforts related to the development of vaccine against COVID-19, which currently affects the global health status and economy. In addition, the commentary aims at addressing potential risks related to the development of COVID-19 vaccine from the global health safety perspective.
引用
收藏
页数:7
相关论文
共 30 条
[1]   A review of comparison study between Corona Viruses (SARS-CoV, MERS-CoV) and Novel Corona Virus (Covid-19) [J].
Al-Qahtani, W. S. ;
Alneghery, L. M. ;
Alqahtani, A. Q. S. ;
AlKahtani, M. D. ;
Alkahtani, S. .
REVISTA MEXICANA DE INGENIERIA QUIMICA, 2020, 19 :201-212
[2]   Immunoinformatics-aided identification of T cell and B cell epitopes in the surface glycoprotein of 2019-nCoV [J].
Baruah, Vargab ;
Bose, Sujoy .
JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (05) :495-500
[3]  
Bhagavathula A., 2020, JMIR PUBLIC HEAL SUR, DOI DOI 10.1101/2020.03.09.20033381
[4]   Emerging infectious diseases: A proactive approach [J].
Bloom, David E. ;
Black, Steven ;
Rappuoli, Rino .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (16) :4055-4059
[5]   The SARS-CoV-2 Vaccine Pipeline: an Overview [J].
Chen, Wen-Hsiang ;
Strych, Ulrich ;
Hotez, Peter J. ;
Bottazzi, Maria Elena .
CURRENT TROPICAL MEDICINE REPORTS, 2020, 7 (02) :61-64
[6]   Effect of thermal ballast loading on temperature stability of domestic refrigerators used for vaccine storage [J].
Chojnacky, Michal ;
Rodriguez, Alexandra L. .
PLOS ONE, 2020, 15 (07)
[7]   Failure-to-success ratios, transition probabilities and phase lengths for prophylactic vaccines versus other pharmaceuticals in the development pipeline [J].
Davis, Matthew M. ;
Butchart, Amy T. ;
Wheeler, John R. C. ;
Coleman, Margaret S. ;
Singer, Dianne C. ;
Freed, Gary L. .
VACCINE, 2011, 29 (51) :9414-9416
[8]   Plant-based vaccines and antibodies to combat COVID-19: current status and prospects [J].
Dhama, Kuldeep ;
Natesan, Senthilkumar ;
Iqbal Yatoo, Mohd. ;
Patel, Shailesh Kumar ;
Tiwari, Ruchi ;
Saxena, Shailendra K. ;
Harapan, Harapan .
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2020, 16 (12) :2913-2920
[9]   The spike protein of SARS-CoV - a target for vaccine and therapeutic development [J].
Du, Lanying ;
He, Yuxian ;
Zhou, Yusen ;
Liu, Shuwen ;
Zheng, Bo-Jian ;
Jiang, Shibo .
NATURE REVIEWS MICROBIOLOGY, 2009, 7 (03) :226-236
[10]   A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic [J].
Funk, Colin D. ;
Laferriere, Craig ;
Ardakani, Ali .
FRONTIERS IN PHARMACOLOGY, 2020, 11